GGrantIndex
Sort

261,768 grants matching gene therapy

Cancer-cell specific therapy: photo-immunotherapy

$1,466,429
Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

$1,466,425
Fernando D Martinez · University Of Arizona · UG3 · FY2020 · HL

Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery

$1,466,058
Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2023 · DK

Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency

$1,465,945
Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2020 · AI

Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells

$1,465,468
Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Evaluation and treatment of drug-resistant epilepsy

$1,465,407
William Theodore · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS

Muscular Dystrophy Cooperative Research Center

$1,465,371
Richard T Moxley · University Of Rochester · U54 · FY2010 · NS

Trio Analysis of Recurrent Pregnancy Loss Integrated Bioinformatics Genomics Study (TRIOS)

$1,465,292
Ruth B Lathi · Stanford University · R01 · FY2021 · HD

Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS

$1,465,258
Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2016 · DA

Comprehensive Sickle Cell Center

$1,465,191
Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2010 · HL

SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)

$1,464,981
Mathew S Maurer · Columbia University Health Sciences · R01 · FY2019 · HL

Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis

$1,464,833
Claudia Cicala · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM

$1,464,631
University Of Texas Sw Med Ctr/Dallas · P01 · FY2002 · DK

GENE THERAPY FOR HEMOPHILIA

$1,464,576
Childrens Hospital Of Philadelphia · P01 · FY2004 · HL

The molecular basis of pregnancy-associated protection from breast cancer

$1,464,539
Gregory J Hannon · Cold Spring Harbor Laboratory · RC2 · FY2009 · CA

Androgen Receptor Action in Castration Resistant Prostate Cancer

$1,464,494
Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2020 · CA

Optical Systems for In Vivo Molecular Imaging of Cancer

$1,464,247
Rebecca Rae Richards-Kortum · Rice University · R01 · FY2007 · CA

SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)

$1,464,245
Mathew S Maurer · Columbia University Health Sciences · R01 · FY2023 · HL

Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions

$1,464,090
Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

Neural Mechanisms of Motivation and Reward

$1,463,991
Barry J Richmond · National Institute Of Mental Health · ZIA · FY2020 · MH

Modulating Cancer Stem Cell Signaling in Thoracic Malignancies

$1,463,788
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment

$1,463,720
David E Fisher · Massachusetts General Hospital · P01 · FY2020 · CA

Formulation of Rational Therapy of Nephrolithiasis

$1,463,525
University Of Texas Sw Med Ctr/Dallas · P01 · FY2004 · DK

Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies

$1,463,315
Hunter Ramsdell Gibbons · Luminary Therapeutics, Inc. · R44 · FY2025 · CA

Whole Genome Association Analysis of Hematopoietic Cell Transplant Outcome

$1,463,168
John Andrew Hansen · Fred Hutchinson Cancer Research Center · R01 · FY2007 · HL